Cargando…

Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis

BACKGROUND: Dyslipidemias are associated with atherosclerotic plaque formation and a prothrombotic state, thus increasing the risk of both atherosclerotic vascular disease and atherothrombotic adverse events. We sought to explore the association between lipoprotein subfractions, overall hemostasis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Poropat Flerin, Tadeja, Božič Mijovski, Mojca, Jug, Borut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448618/
https://www.ncbi.nlm.nih.gov/pubmed/36082237
http://dx.doi.org/10.1155/2022/2993309
_version_ 1784784104401666048
author Poropat Flerin, Tadeja
Božič Mijovski, Mojca
Jug, Borut
author_facet Poropat Flerin, Tadeja
Božič Mijovski, Mojca
Jug, Borut
author_sort Poropat Flerin, Tadeja
collection PubMed
description BACKGROUND: Dyslipidemias are associated with atherosclerotic plaque formation and a prothrombotic state, thus increasing the risk of both atherosclerotic vascular disease and atherothrombotic adverse events. We sought to explore the association between lipoprotein subfractions, overall hemostasis, and coronary calcifications in individuals at intermediate cardiovascular risk. METHODS: Consecutive statin-naive individuals at intermediate cardiovascular risk referred for coronary artery calcium score (CACS) scanning were included. CACS was assessed using a 128-slice dual-source CT scanner. Traditional lipid profile, high-density lipoprotein (HDL) subfractions 2 and 3, and small dense low-density lipoproteins (sdLDL) were measured with commercially available assays. Overall hemostatic (OHP) and coagulation potentials (OCP) were measured spectrophotometrically, using fibrin aggregation curves after exposure to thrombin and recombinant tissue-type plasminogen activator, respectively. Overall fibrinolytic potential (OFP) was calculated as a difference between the two areas under curves. RESULTS: We included 160 patients (median age 63 (interquartile range (IQR), 56-71 years, 52% women, and median CACS 8, IQR 0-173 Agatston units). HDL3 levels—but not sdLDL or hemostatic potentials—were significantly associated with CACS zero, even after adjusting for age, sex, arterial hypertension, dyslipidemia, diabetes, and smoking history (OR 0.980 (0.962-0.999), p = 0.034). HDL3 was also significantly associated with OCP (r = −0.232, p adjusted for age and sex 0.037). CONCLUSIONS: In patients at intermediate cardiovascular risk, HDL3 is associated with both subclinical atherosclerosis and overall coagulation. Our findings are in line with studies reporting on an inverse relationship between HDL3 and atherosclerosis and provide one possible mechanistic explanation for the association between novel lipid biomarkers and coagulation derangements.
format Online
Article
Text
id pubmed-9448618
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94486182022-09-07 Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis Poropat Flerin, Tadeja Božič Mijovski, Mojca Jug, Borut Dis Markers Research Article BACKGROUND: Dyslipidemias are associated with atherosclerotic plaque formation and a prothrombotic state, thus increasing the risk of both atherosclerotic vascular disease and atherothrombotic adverse events. We sought to explore the association between lipoprotein subfractions, overall hemostasis, and coronary calcifications in individuals at intermediate cardiovascular risk. METHODS: Consecutive statin-naive individuals at intermediate cardiovascular risk referred for coronary artery calcium score (CACS) scanning were included. CACS was assessed using a 128-slice dual-source CT scanner. Traditional lipid profile, high-density lipoprotein (HDL) subfractions 2 and 3, and small dense low-density lipoproteins (sdLDL) were measured with commercially available assays. Overall hemostatic (OHP) and coagulation potentials (OCP) were measured spectrophotometrically, using fibrin aggregation curves after exposure to thrombin and recombinant tissue-type plasminogen activator, respectively. Overall fibrinolytic potential (OFP) was calculated as a difference between the two areas under curves. RESULTS: We included 160 patients (median age 63 (interquartile range (IQR), 56-71 years, 52% women, and median CACS 8, IQR 0-173 Agatston units). HDL3 levels—but not sdLDL or hemostatic potentials—were significantly associated with CACS zero, even after adjusting for age, sex, arterial hypertension, dyslipidemia, diabetes, and smoking history (OR 0.980 (0.962-0.999), p = 0.034). HDL3 was also significantly associated with OCP (r = −0.232, p adjusted for age and sex 0.037). CONCLUSIONS: In patients at intermediate cardiovascular risk, HDL3 is associated with both subclinical atherosclerosis and overall coagulation. Our findings are in line with studies reporting on an inverse relationship between HDL3 and atherosclerosis and provide one possible mechanistic explanation for the association between novel lipid biomarkers and coagulation derangements. Hindawi 2022-08-30 /pmc/articles/PMC9448618/ /pubmed/36082237 http://dx.doi.org/10.1155/2022/2993309 Text en Copyright © 2022 Tadeja Poropat Flerin et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Poropat Flerin, Tadeja
Božič Mijovski, Mojca
Jug, Borut
Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
title Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
title_full Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
title_fullStr Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
title_full_unstemmed Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
title_short Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
title_sort association between lipoprotein subfractions, hemostatic potentials, and coronary atherosclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448618/
https://www.ncbi.nlm.nih.gov/pubmed/36082237
http://dx.doi.org/10.1155/2022/2993309
work_keys_str_mv AT poropatflerintadeja associationbetweenlipoproteinsubfractionshemostaticpotentialsandcoronaryatherosclerosis
AT bozicmijovskimojca associationbetweenlipoproteinsubfractionshemostaticpotentialsandcoronaryatherosclerosis
AT jugborut associationbetweenlipoproteinsubfractionshemostaticpotentialsandcoronaryatherosclerosis